Key Dates

Related Announcements

• March 12, 2021 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed). See PAR-21-122.
• March 12, 2021 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed). See PAR-21-123.
• March 12, 2021 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed). See PAR-21-124.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-21-122, PAR-21-123 and PAR-21-124. These Funding Opportunity Announcements (FOAs) have been extended to add a new application due date of June 20, 2024.

An additional receipt date has been added, June 20, 2024, for new and resubmission applications for all 3 FOAs. This Notice of Funding Opportunity now expires on June 21, 2024. The changes below are in bold italics. 

The Notice of Funding Opportunities currently reads as:

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: February 21, 2024

The Notice of Funding Opportunity has been modified as follows:

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: June 21, 2024

All other aspects of these FOAs remain the same.

Inquiries

Please direct all inquiries to:

Becky Roof, PhD
Division of Translational Research
National Institute of Neurological Disorders and Stroke (NINDS)
Email: [email protected]